Literature DB >> 1972995

Comparison of the effects of three indirect dopamine agonists, GK 13, GBR 12783 and dexamphetamine on behavioural tests involving central catecholaminergic transmissions.

D Duterte-Boucher1, J M Kamenka, J Costentin.   

Abstract

GK 13 (N-[1-(2-benzo (b) thiophenyl)-cyclohexyl] piperidine), GBR 12783 (1-[2-(diphenylmethoxy)-ethyl] 4-(3-phenyl propenyl)-piperazine and dexamphetamine are three indirect catecholaminergic agonists, acting via different neurochemical mechanisms. We have compared their effects in rodents, in several behavioral tests. All three drugs increased locomotion. The stimulant locomotor effect of dexamphetamine was more easily antagonized by haloperidol than that of GBR 12783 and GK 13. Only dexamphetamine reversed reserpine-induced akinesia. This reversal was prevented by pretreatment with either GK 13 or GBR 12783. The three drugs reduced pentobarbital sleeping time in mice. They induced rotation ipsilateral to a unilateral 6-OHDA lesion of the nigrostriatal dopaminergic pathway. The stereotypies induced by GK 13 and GBR 12783 were essentially limited to sniffing. Haloperidol-induced catalepsy was apparently more easily antagonized by dexamphetamine than by GK 13 or GBR 12783. GK 13 and GBR 12783 had no significant effects on body temperature. The three drugs displayed an anti-immobility effect in the "despair test". Dexamphetamine and GK 13 reversed the hypothermia induced by apomorphine (16 mg/kg), as well as reserpine-induced hypothermia and reserpine-induced ptosis. Dexamphetamine induced a dose-dependent anorectic effect, whereas GK 13 and GBR 12783 induced only a brief and partial anorexia. Similar observations were made on water intake. Pretreatment with either GBR 12783 or GK 13 did not affect the dexamphetamine-induced anorexia. Effects of the three drugs are discussed by reference to their known neurochemical properties on catecholaminergic transmission.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972995     DOI: 10.1007/bf02244052

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

1.  On the mechanism of antidepressant action of imipraminelike drugs.

Authors:  F SULSER; J WATTS; B B BRODIE
Journal:  Ann N Y Acad Sci       Date:  1962-01-13       Impact factor: 5.691

2.  Bioassay of Rauwolfia roots and alkaloids.

Authors:  B RUBIN; M H MALONE; M H WAUGH; J C BURKE
Journal:  J Pharmacol Exp Ther       Date:  1957-06       Impact factor: 4.030

3.  Effects of the d- and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain.

Authors:  J C Holmes; C O Rutledge
Journal:  Biochem Pharmacol       Date:  1976-02-15       Impact factor: 5.858

Review 4.  Biochemistry and behavior: some central actions of amphetamine and antipsychotic drugs.

Authors:  P M Groves; G V Rebec
Journal:  Annu Rev Psychol       Date:  1976       Impact factor: 24.137

5.  Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats.

Authors:  E Carboni; A Imperato; L Perezzani; G Di Chiara
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

6.  Relative potencies of d- and l-amphetamine on the release of dopamine from cat brain in vivo.

Authors:  C C Chiueh; K E Moore
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1974-01

7.  Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex.

Authors:  R E Heikkila; H Orlansky; C Mytilineou; G Cohen
Journal:  J Pharmacol Exp Ther       Date:  1975-07       Impact factor: 4.030

8.  d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes.

Authors:  M Raiteri; A Bertollini; F Angelini; G Levi
Journal:  Eur J Pharmacol       Date:  1975-11       Impact factor: 4.432

9.  Antagonism of hypothermia and behavioral response to apomorphine: a simple, rapid and discriminating test for screening antidepressants and neuroleptics.

Authors:  A J Puech; R Chermat; M Poncelet; L Doaré; P Simon
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

10.  Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.

Authors:  T Zetterström; T Sharp; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1984-10-30       Impact factor: 4.432

View more
  4 in total

1.  Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission.

Authors:  P Bredeloux; I Dubuc; J Costentin
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

2.  A new model of the disrupted latent inhibition in C57BL/6J mice after bupropion treatment.

Authors:  Tatiana Lipina; John Roder
Journal:  Psychopharmacology (Berl)       Date:  2009-12-16       Impact factor: 4.530

3.  Effects of various direct or indirect dopamine agonists on the latency of the acoustic startle response in rats.

Authors:  B Naudin; S Canu; J Costentin
Journal:  J Neural Transm Gen Sect       Date:  1990

4.  Invariance of the density of dopamine uptake sites and dopamine metabolism in the rat brain after a chronic treatment with the dopamine uptake inhibitor GBR 12783.

Authors:  D Boulay; I Leroux-Nicollet; D Duterte-Boucher; L Naudon; J Costentin
Journal:  J Neural Transm Gen Sect       Date:  1994
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.